Form 10-K Celator Pharmaceuticals For: Dec 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. SPY
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to Form 10-K Celator Pharmaceuticals For: Dec 31

NDA, MAA Remain Key Focal Points for Celator Pharma (CPXX) Moving Forward; Roth Affirms at 'Buy'

March 21, 2016 11:31 AM EDT

Roth Capital affirms Celator Pharmaceuticals (Nasdaq: CPXX) with a Buy rating and $22 price target after the company announced FY15 results earlier.

Analyst Joseph Pantginis noted that Celator posted FY15 EPS of ($0.57), which compares with the firm's ($0.56) estimate.

Pantginis also commented: With historic data in hand and a significantly de-risked program, in... More